ScholarIQanswers from OpenAlex

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

PaperCitations, authors & open-access status

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 have?

ScholarIQcitation count

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 has 186 citations in the OpenAlex counts ScholarIQ stores.

When was Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 published?

ScholarIQyear

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 has 2021 year in the ScholarIQ index.

What is the open-access status of Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19?

ScholarIQoa status

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 has hybrid oa status in the ScholarIQ index.

What is the DOI of Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19?

ScholarIQdoi

The DOI for Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 is on the source record.

What is the PMID of Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19?

ScholarIQpmid

The PMID for Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 is on the source record.

What is the OpenAlex record for Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19?

ScholarIQopenalex

The OpenAlex for Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial